disorder/disease
|
gene/chromosomal region
|
synonym
|
method 1
|
method 2
|
material (if different from 3-5ml EDTA blood or 1-5 µg DNA)
|
analysis is performed in a reference laboratory
|
A
|
|
|
|
|
|
|
Albright syndrome |
GNAS |
|
sequencing analysis |
MLPA |
|
|
alpha-1-antitrypsin deficiency |
SERPINA1 |
AAT deficiency |
sequencing analysis |
|
|
|
alpha thalassemia |
HBA1, HBA2 |
hemoglobinopathy |
MLPA |
sequencing analysis |
|
|
Angelman syndrome |
SNRPN gene region (15q11-q13) |
AS |
methylation-specific MLPA |
|
|
|
Angelman syndrome |
UBE3A |
AS |
sequencing analysis |
|
|
|
antithrombin 3 deficiency |
SERPINC1 |
|
sequencing analysis |
MLPA |
|
x |
Alström syndrome |
ALMS1 |
ALMS |
sequencing analysis |
|
|
|
B
|
|
|
|
|
|
|
Beckwith-Wiedemann syndrome |
11p15.5 |
BWS |
methylation-specific MLPA |
|
|
|
Beckwith-Wiedemann syndrome |
CDKN1C |
BWS |
sequencing analysis |
|
|
|
beta thalassemia |
HBB |
hemoglobinopathy |
sequencing analysis |
MLPA |
|
|
biotinidase deficiency |
BTD |
|
sequencing analysis |
|
|
|
biotin-responsive basal ganglia disease |
SLC19A3 |
|
sequencing analysis |
|
|
|
Birt-Hogg-Dube syndrome |
FLCN |
Hornstein-Knickenberg syndrome, Fibrofolliculomas with Trichodiscomas and Acrochordons, BHD syndrome |
sequencing analysis |
|
|
|
Bloom syndrome |
BLM/RECQL3 |
|
sequencing analysis |
|
|
|
C
|
|
|
|
|
|
|
cerebral arteriopathy with subcortical infarcts and leukoencephalopathy |
NOTCH3 |
CADASIL |
sequencing analysis |
|
|
|
Charcot-Marie-Tooth disease type 1A |
PMP22 |
CMT1A |
MLPA |
sequencing analysis |
|
|
CINCA syndrome (CIAS1/NLRP3) |
NLRP3 |
|
sequencing analysis |
|
|
|
Cohen syndrome |
VPS13B |
|
sequencing analysis |
MLPA |
|
|
congenital adrenal hyperplasia |
CYP21A2 |
AGS, CAH |
sequencing analysis |
MLPA |
|
|
cystic fibrosis |
CFTR |
mucoviscidosis |
sequencing analysis |
MLPA |
|
|
D
|
|
|
|
|
|
|
deafness |
GJB2 |
Connexin 26, Cx26 |
sequencing analysis |
MLPA |
|
|
DiGeorge syndrome |
22q11.2 |
CATCH22, Shprintzen syndrome |
MLPA |
|
|
|
dihydropyrimidine dehydrogenase deficiency |
DPYD |
DPD |
fragment analysis |
|
|
|
Dravet syndrome |
SCN1A |
SMEI |
sequencing analysis |
MLPA |
|
|
dystonia, dopa-responsive |
GCH1 |
Segawa syndrome, DYT5; |
sequencing analysis |
MLPA |
|
|
dystonia, dopa-responsive |
TH |
Segawa syndrome |
sequencing analysis |
MLPA |
|
|
E
|
|
|
|
|
|
|
episodic ataxia type 2 |
CACNA1A |
|
sequencing analysis |
|
|
|
F
|
|
|
|
|
|
|
facioscapulohumeral muscular dystrophy |
DUX4/DUX4L1 |
FSHD |
fragment analysis |
|
10ml EDTA blood |
x |
familial Mediterranean fever |
MEFV |
FMF |
sequencing analysis |
|
|
|
Fragile X syndrome |
FMR1 |
FraX, POF, FXTAS |
fragment analysis |
|
|
|
Friedreich ataxia |
FXN |
|
fragment analysis |
|
|
x |
frontotemporal dementia, ALS |
c9orf72 |
|
fragment analysis |
|
|
x |
fructose intolerance |
ALDOB |
|
sequencing analysis |
|
|
|
G
|
|
|
|
|
|
|
glucose-6-phosphate dehydrogenase deficiency |
G6PD |
|
sequencing analysis |
|
|
|
GLUT1 deficiency |
SLC2A1 |
|
sequencing analysis |
MLPA |
|
|
growth hormone deficiency |
GH1 |
|
sequencing analysis |
MLPA |
|
|
H
|
|
|
|
|
|
|
hereditary neuropathy with liability to pressure palsies |
PMP22 |
HNPP |
MLPA |
sequencing analysis |
|
|
hereditary pancreatitis |
PRSS1 |
|
sequencing analysis |
|
|
|
hereditary pancreatitis |
SPINK1 |
|
sequencing analysis |
|
|
|
hereditary pancreatitis |
CFTR |
|
sequencing analysis |
|
|
|
hyper-IgD syndrome |
MVK |
|
sequencing analysis |
|
|
|
I
|
|
|
|
|
|
|
IgVH mutation status |
IgVH |
immunoglobulin heavy-chain variable-region |
sequencing analysis |
|
|
x |
infertility (CBAVD) |
CFTR |
CAVD |
sequencing analysis |
|
|
|
L
|
|
|
|
|
|
|
Lesch-Nyhan syndrome |
HPRT1 |
Kelley-Seegmiller syndrome |
sequencing analysis |
MLPA |
|
|
leukemia (BCR-ABL1), qualitative and quantitative |
BCR-ABL1, t(9;22)(q34;11) |
ALL, AML, Philadelphia |
qPCR |
fragment analysis |
|
|
leukemia, acute myeloid (FLT3-ITD) |
FLT3-ITD |
Internal tandem duplication |
sequencing analysis |
|
|
|
leukemia, acute promyelocytic (PML-RARA), qualitative and quantitative |
PML-RARA, t(15;17)(q22;q21) |
PML-RARA, t(15;17); AML M3, APL |
qPCR |
fragment analysis |
|
|
leukemia, chronic myeloid (ABL1) |
ABL1 |
|
sequencing analysis |
|
|
|
leukemia and lymphoma (TP53) |
TP53 |
|
sequencing analysis |
|
|
|
M
|
|
|
|
|
|
|
McCune-Albright syndrome |
GNAS |
|
sequencing analysis |
|
|
|
Morbus Fabry |
GLA |
|
sequencing analysis |
MLPA |
|
|
Morbus Gaucher |
GBA |
|
sequencing analysis |
|
|
x |
Morbus Meulengracht |
UGT1A1 |
Gilbert syndrome |
sequencing analysis |
|
|
|
Morbus Wilson |
ATP7B |
|
sequencing analysis |
MLPA |
|
|
MTHFR deficiency |
MTHFR |
|
sequencing analysis |
|
|
|
muscular dystrophy Duchenne/Becker |
DMD |
DMD, BMD |
MLPA |
sequencing analysis |
|
|
myotonic dystrophy type 1 |
DMPK |
DM1, Curschmann-Steinert syndrome |
fragment analysis |
|
10ml EDTA blood |
x |
myotonic dystrophy type 2 |
CNBP |
DM2, PROMM |
fragment analysis |
|
10ml EDTA blood |
x |
N
|
|
|
|
|
|
|
neoplasm, myeloproliferative (CALR) |
CALR |
|
sequencing analysis |
|
|
|
neoplasm, myeloproliferative (JAK2) |
JAK2 |
|
sequencing analysis |
|
|
|
neoplasm, myeloproliferative (MPL) |
MPL |
|
sequencing analysis |
|
|
|
Nudix Hydrolase (NUDT15) genotyping |
NUDT15 |
|
sequencing analysis |
|
|
|
O
|
|
|
|
|
|
|
Ondine syndrome |
PHOX2B |
CCHS |
fragment analysis |
sequencing analysis |
|
|
P
|
|
|
|
|
|
|
Pelizaeus-Merzbacher disease |
PLP1 |
|
MLPA |
sequencing analysis |
|
|
Peutz-Jeghers syndrome |
STK11 |
Polyposis, hamartomatous intestinal, polyps-and-spots syndrome |
sequencing analysis |
MLPA |
|
|
plasminogen activator inhibitor-1 deficiency |
PAI1 |
SERPINE1 |
sequencing analysis |
|
|
|
Platelet disorder, familial, with associated myeloid malignancy (FDP/AML) |
RUNX1 |
|
sequencing analysis |
MLPA |
|
|
Pleuropulmonary blastoma |
DICER1 |
|
sequencing analysis |
|
|
|
Prader-Willi syndrome |
SNRPN gene region (15q11-q13) |
PWS |
methylation-specific MLPA |
|
|
|
primary hyperoxaluria |
AGXT |
|
sequencing analysis |
MLPA |
|
|
pyridoxine-dependent epilepsy |
ALDH7A1 |
|
sequencing analysis |
|
|
|
R
|
|
|
|
|
|
|
renal glucosuria |
SLC5A2 |
Diabetes renalis; Diabetes innocens / innocuu |
sequencing analysis |
|
|
|
Retinitis pigmentosa 3 |
RPGR |
|
sequencing analysis |
|
|
|
Retinitis pigmentosa |
RPE65 |
LCA, RP |
sequencing analysis |
MLPA |
|
|
retinoblastoma |
RB1 |
|
sequencing analysis |
MLPA |
|
|
S
|
|
|
|
|
|
|
SHOX deficiency |
SHOX |
Léri-Weill syndrome |
MLPA |
sequencing analysis |
|
|
sickle cell anemia |
HBB (c.20A>T) |
HbS |
sequencing analysis |
|
|
|
Silver-Russell syndrome |
7p12.1, 7q32.2 |
SRS |
methylation-specific MLPA |
|
|
|
Silver-Russell syndrome |
11p15.5 |
SRS |
methylation-specific MLPA |
|
|
|
small fiber neuropathy |
SCN9A |
|
sequencing analysis |
|
|
|
spinal muscular atrophy |
SMN1 |
SMA |
MLPA |
|
|
|
spinocerebellar ataxia 1, 2, 3, 6, 7, 17 |
ATXN1, ATXN2, ATXN3, CACNA1A, ATXN7, TBP |
SCA1, SCA2, SCA3, SCA6, SCA7, SCA17 |
fragment analysis |
|
|
|
T
|
|
|
|
|
|
|
T-cell receptor gamma rearrangement |
TCRG |
TCR gamma |
sequencing analysis |
|
|
x |
thiopurine methyltransferase deficiency |
TPMT |
|
sequencing analysis |
|
|
|
thrombotic thrombocytopenic purpura |
ADAMTS13 |
TTP |
sequencing analysis |
|
|
|
transthyretin-related amyloidosis |
TTR |
TTR-FAP |
sequencing analysis |
sequencing analysis |
|
|
TRAPS (TNFRSF1A) |
TNFRSF1A |
familial Hibernian fever |
sequencing analysis |
|
|
|
U
|
|
|
|
|
|
|
uniparental disomy 7 |
chromosome 7 |
Silver-Russell syndrome |
fragment analysis |
|
in addition to the index, material of both parents is also required for the analysis |
|
uniparental disomy 11 |
chromosome 11 |
Beckwith-Wiedemann syndrome, Silver-Russell syndrome |
fragment analysis |
|
in addition to the index, material of both parents is also required for the analysis |
|
uniparental disomy 14 |
chromosome 14 |
Temple syndrome, Kagami-Ogata syndrome |
fragment analysis |
|
in addition to the index, material of both parents is also required for the analysis |
|
uniparental disomy 15 |
chromosome 15 |
Prader-Willi syndrome, Angelman syndrome |
fragment analysis |
|
in addition to the index, material of both parents is also required for the analysis |
|
V
|
|
|
|
|
|
|
von Hippel-Lindau syndrome |
VHL |
|
sequencing analysis |
MLPA |
|
|
von Willebrand disease |
VWF |
|
sequencing analysis |
MLPA |
|
|
W
|
|
|
|
|
|
|
Wiskott-Aldrich syndrome |
WAS |
|
sequencing analysis |
|
|
|
X
|
|
|
|
|
|
|
X-linked adrenoleukodystrophy |
ABCD1 |
|
sequencing analysis |
|
|
|